About Renalytix - ADR (RNLX)
Renalytix PLC operates as an artificial intelligence-enabled in vitro diagnostics company. The Company focuses on optimizing clinical management of kidney disease. Renalytix serves customers worldwide.
- USD0.67
- USD0.67
- USD0.59
- 618.41k
Stock News
3 hours ago
Many Canadians are delaying filing their taxes out of fear of owing money, survey says
Yahoo
3 hours ago
AI Boom’s Secret Winners? The Companies Expected to Power It
Yahoo
3 hours ago
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo
4 hours ago
Should You Investigate Keysight Technologies, Inc. (NYSE:KEYS) At US$149?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
